Skip to Content

Invesco Pharmaceuticals ETF PJP

Medalist Rating as of | See Invesco Investment Hub

Morningstar’s Analysis PJP

Will PJP outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Invesco Pharmaceuticals ETF earns a Morningstar Medalist Rating of Negative with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PJP

  • Current Portfolio Date
  • Equity Holdings 24
  • Bond Holdings 0
  • Other Holdings 3
  • % Assets in Top 10 Holdings 52.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
5.83
14,527,832
Healthcare
5.83
14,511,641
Healthcare
5.82
14,497,153
Healthcare
5.75
14,311,850
Healthcare
5.74
14,309,256
Healthcare
5.70
14,192,908
Healthcare
5.64
14,054,210
Healthcare
5.59
13,926,676
Healthcare
3.55
8,855,280
Healthcare
3.49
8,682,957
Healthcare